Method and compositions for making ACSF and ACSF antagonists

Details Method and compositions for making ACSF and ACSF antagonists Method and compositions for making ACSF and ACSF antagonists

1992-11-13

1994-05-17

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

424 88, 514 2, 530300, 530324, A61K 3702, A61K 3724, A61K 3764

Patent

active

053128109

ABSTRACT:
Compositions comprising the C-terminal portion of adenylate cyclase stimulating factor (ACSF) are useful for making ACSF-specific antisera.

REFERENCES:
patent: 4968669 (1990-11-01), Rosenblatt et al.
patent: 5116952 (1992-05-01), Martin et al.
Robbins Pathological Basis of Disease, 4th edition (1989) R. S. Cotran, et al. (ed.s), pp. 35-37, 292-296.
Abeloff, M. D., New Engl. J. Med. 317:1598-1600 (1987) "Paraneoplastic syndromes".
Broadus, A. E., et al., New Engl. J. Med. 319:556-563 (1988), "Humoral hypercalcemia of cancer".

Affiliated with

Also associated with

Rating

Method and compositions for making ACSF and ACSF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and compositions for making ACSF and ACSF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for making ACSF and ACSF antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-876828